Connection
Jesse Schold to Disease-Free Survival
This is a "connection" page, showing publications Jesse Schold has written about Disease-Free Survival.
|
|
Connection Strength |
|
 |
|
 |
|
0.044 |
|
|
|
-
Dunbar EM, Buzzeo MP, Levine JB, Schold JD, Meier-Kriesche HU, Reddy V. The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease. Haematologica. 2008 Dec; 93(12):1852-8.
Score: 0.017
-
Reddy V, Winer AG, Eksioglu E, Meier-Kriesche HU, Schold JD, Wingard JR. Interleukin 12 is associated with reduced relapse without increased incidence of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005 Dec; 11(12):1014-21.
Score: 0.014
-
Reddy V, Iturraspe JA, Tzolas AC, Meier-Kriesche HU, Schold J, Wingard JR. Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease. Blood. 2004 Jun 01; 103(11):4330-5.
Score: 0.013